期刊文献+

WHO药品资格预审规划对我国制药企业国际化的启示 被引量:5

Introduction of WHO Prequalification Program and Inspiration for the Internalization of Domestic Pharmaceutical Manufacturers
下载PDF
导出
摘要 目的推广对WHO药品资格预审规划的认识,为我国医药产品走向国际主流市场提出相关策略。方法通过分析WHO药品资格预审规划机构工作程序,从不同角度阐述药品资格预审规划的重要性。结果与结论深入学习国际组织相关法规和技术要求、建立符合国际标准的药品质量管理体系,是有效推进我国制药企业产品参与相关项目国际采购、早日进入国际市场的最佳途径。 Objective Spread awareness about the WHO prequalification program,and propose the related strategies for our pharmaceutical products into the international mainstream market.Methods Analyze the significance of WHO prequalification program in different respects,through introducing the program in terms of its organization structure,purpose,strategy and procedure,then put forward the inspiration.Results and Conclusion In order to effectively promote the domestic pharmaceutical products to be involved in the international procurement and enter the international market as soon as possible,the best ways might be as follows: to understand and pay close attention to the significance of attending the prequalification program,to learn further the relevant regulations of international organization and requirements of technology,to form the system of drug quality management which meets the international standards.
出处 《中国药事》 CAS 2011年第4期402-404,共3页 Chinese Pharmaceutical Affairs
关键词 世界卫生组织 药品资格预审规划 工作程序 药品国际化 策略 WHO prequalification program procedure drug internationalization strategy
  • 相关文献

参考文献8

  • 1World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations.Forty-third Report[M].Geneva,Switzerland,2009:53-56.
  • 2WHO.WHO Pharmaceuticals Newsletter No.2[Z].2005:16-17.
  • 3WHO.WHO Prequalification.Programme[EB/OL].[2010-12-14].http:// mednet3.who.int/prequel.
  • 4WHO.WHO Drug Information Vol.19,No.1[Z].2005:36-37.
  • 5WHO.WHO Prequalification Programme Annual Report[Z].2006:4-5.
  • 6Editorial,The Lancet,Vol.364,No.9448[Z].2004:1830-1831.
  • 7WHO.WHO Prequalification Programme Annual Report[Z].2005:6-7.
  • 8WHO.WHO Prequalification of medicines by WHO.[EB/OL].(2010-08-10)[2010-12-24].http://www.who.int/mediacentre/factsheets/fs278/en/index.html.

同被引文献59

  • 1叶江,谈谭.试论国际制度的合法性及其缺陷——以国际安全制度与人权制度为例[J].世界经济与政治,2005(12):42-49. 被引量:20
  • 2胡冰.药品预认证程序创立的必然性与重要性[J].亚太传统医药,2007,3(8):91-92. 被引量:4
  • 3World Health Organization. WHO prequalification of medi eine programme update for 2006 [R]. Geneva: World Health Organization, 2007: 1-16.
  • 4World Health Organization. Procedure for prequalification of pharmaceutical products. Revision [ R]. Geneva: World Health Organization, 2011:374 -390.
  • 5World Health Organization. WHO prequalification of medi- cines for reproductive health [R]. Geneva: World Health Organization, 2012: 1-5.
  • 6World Health Organization. WHO list of prequalified medici- nal products [EB/OL]. [2012-11-05]. www. who. int/ prequal.
  • 7World Health Organization. Guidelines on submission of doc- umentation for a multisource (generic) finished product for the WHO prequalification of medicines programme: quality part [R]. Geneva: World Health Organization, 2012: 122-157.
  • 8World Health Organization. Guidelines on submission of doc- umentation for a multisource (generic) finished product: general format: preparation of product dossiers in common technical document format [R]. Geneva: World Health Or ganization, 2011:418 -427.
  • 9World Health Organization. Procedurefor assessing the ac ceptability, in principle, of active pharmaceutical ingredi ents for use in pharmaceutical products [ R]. Geneva World Health Organization, 2009: 149-161.
  • 10World Health Organization. WHO list of prequalified active pharmaceutical ingredients (APIs) [EB/OL]. [2012- 11- 05]. www. who. int/prequal.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部